190 related articles for article (PubMed ID: 34907613)
41. Road Less Traveled: Drug Hypersensitivity to Fluoroquinolones, Vancomycin, Tetracyclines, and Macrolides.
Zhu LJ; Liu AY; Wong PH; Arroyo AC
Clin Rev Allergy Immunol; 2022 Jun; 62(3):505-518. PubMed ID: 35092578
[TBL] [Abstract][Full Text] [Related]
42. Individual risk assessment in the diagnosis of immediate type drug hypersensitivity reactions to betalactam and non-betalactam antibiotics using basophil activation test: a single center experience.
Thinnes A; Merk HF; Wurpts G; Röseler S; Lehmann S; Tenbrock K; Baron JM; Balakirski G
Cutan Ocul Toxicol; 2018 Dec; 37(4):309-318. PubMed ID: 29508626
[TBL] [Abstract][Full Text] [Related]
43. A UK national survey of investigations for beta-lactam hypersensitivity - heterogeneity in practice and a need for national guidelines - on behalf of British Society for Allergy and Clinical Immunology (BSACI).
Richter AG; Nasser SM; Krishna MT
Clin Exp Allergy; 2013 Aug; 43(8):941-9. PubMed ID: 23889247
[TBL] [Abstract][Full Text] [Related]
44. The Safety of the Direct Drug Provocation Test in Beta-Lactam Hypersensitivity in Children: A Systematic Review and Meta-Analysis.
Srisuwatchari W; Phinyo P; Chiriac AM; Saokaew S; Kulalert P
J Allergy Clin Immunol Pract; 2023 Feb; 11(2):506-518. PubMed ID: 36528293
[TBL] [Abstract][Full Text] [Related]
45. Don't we overestimate drug allergies in children?
Podlecka D; Jerzyńska J; Brzozowska A
Int J Occup Med Environ Health; 2023 Nov; 36(5):632-642. PubMed ID: 37750429
[TBL] [Abstract][Full Text] [Related]
46. Suspected Reaction with Cephalosporin May Be a Predictive Factor for β-Lactam Allergy in Children.
Eser Simsek I; Tuba Cogurlu M; Aydogan M
Int Arch Allergy Immunol; 2019; 178(3):248-254. PubMed ID: 30517941
[TBL] [Abstract][Full Text] [Related]
47. Antibiotic allergy in cystic fibrosis.
Parmar JS; Nasser S
Thorax; 2005 Jun; 60(6):517-20. PubMed ID: 15923254
[TBL] [Abstract][Full Text] [Related]
48. Allergy clinic patients' drug hypersensitivity.
Frachowicz-Guerreiro K; Wardzyńska A; Kowalski ML
Allergol Immunopathol (Madr); 2022; 50(3):77-84. PubMed ID: 35527659
[TBL] [Abstract][Full Text] [Related]
49. Provocation tests in diagnosing drug hypersensitivity.
Bousquet PJ; Gaeta F; Bousquet-Rouanet L; Lefrant JY; Demoly P; Romano A
Curr Pharm Des; 2008; 14(27):2792-802. PubMed ID: 18991698
[TBL] [Abstract][Full Text] [Related]
50. Adding a second skin prick test reading and modifying the cut-off for beta-lactam-specific IgE enhances the sensitivity in the routine diagnostic workup for immediate beta-lactam hypersensitivity.
Rosti B; Mahler V
Contact Dermatitis; 2020 Nov; 83(5):361-371. PubMed ID: 32462721
[TBL] [Abstract][Full Text] [Related]
51. Positive drug provocation with beta-lactam antibiotics in children: A single test may not be enough.
Moral L; Latorre S; Toral T; Marco N; Canals F; Forniés MJ; González MC; García-Avilés B
Allergol Immunopathol (Madr); 2022; 50(5):148-152. PubMed ID: 36086975
[TBL] [Abstract][Full Text] [Related]
52. Direct drug provocation test for the diagnosis of self-reported, mild and immediate drug hypersensitivity reaction in children and adolescents: our real-life experience.
Nisticò D; Passanisi S; Oppedisano EM; Caminiti L; Marino A; Ruggeri P; Crisafulli G; Pajno GB
Minerva Pediatr (Torino); 2021 Jun; 73(3):209-214. PubMed ID: 32418402
[TBL] [Abstract][Full Text] [Related]
53. Beta-lactam allergy in adults with cystic fibrosis.
Burrows JA; Nissen LM; Kirkpatrick CM; Bell SC
J Cyst Fibros; 2007 Jul; 6(4):297-303. PubMed ID: 17182289
[TBL] [Abstract][Full Text] [Related]
54. Oral challenge without skin tests in children with non-severe beta-lactam hypersensitivity: Time to change the paradigm?
Moral L; Caubet JC
Pediatr Allergy Immunol; 2017 Dec; 28(8):724-727. PubMed ID: 28892222
[TBL] [Abstract][Full Text] [Related]
55. Diagnostic evaluation of hypersensitivity reactions to beta-lactam antibiotics in a large population of children.
Zambonino MA; Corzo JL; Muñoz C; Requena G; Ariza A; Mayorga C; Urda A; Blanca M; Torres MJ
Pediatr Allergy Immunol; 2014 Feb; 25(1):80-7. PubMed ID: 24329898
[TBL] [Abstract][Full Text] [Related]
56. Diagnostic evaluation and risk factors for drug allergies in children: from clinical history to skin and challenge tests.
Arikoglu T; Aslan G; Batmaz SB; Eskandari G; Helvaci I; Kuyucu S
Int J Clin Pharm; 2015 Aug; 37(4):583-91. PubMed ID: 25822038
[TBL] [Abstract][Full Text] [Related]
57. Nonimmediate β-lactam reactions in patients with cystic fibrosis.
Whitaker P; Naisbitt D; Peckham D
Curr Opin Allergy Clin Immunol; 2012 Aug; 12(4):369-75. PubMed ID: 22729028
[TBL] [Abstract][Full Text] [Related]
58. Successful meropenem desensitization in a patient with cystic fibrosis.
Wilson DL; Owens RC; Zuckerman JB
Ann Pharmacother; 2003 Oct; 37(10):1424-8. PubMed ID: 14519038
[TBL] [Abstract][Full Text] [Related]
59. Single-dose prolonged drug provocation test, without previous skin testing, is safe for diagnosing children with mild non-immediate reactions to beta-lactams.
Prieto A; Muñoz C; Bogas G; Fernández-Santamaría R; Palomares F; Mayorga C; Salas M; Doña I; Torres MJ
Allergy; 2021 Aug; 76(8):2544-2554. PubMed ID: 33650109
[TBL] [Abstract][Full Text] [Related]
60. Skin tests are important in children with β-lactam hypersensitivity, but may be reduced in number.
Diaferio L; Chiriac AM; Leoni MC; Castagnoli R; Caimmi S; Miniello VL; Demoly P; Caimmi D
Pediatr Allergy Immunol; 2019 Jun; 30(4):462-468. PubMed ID: 30734416
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
